产品

您的位置:首页 > 食品资讯 > 外讯导读 > 欧盟评估非转基因Cellulosimicrobiumfunkei菌株AE-AMT生产的α-淀粉酶的安全性

欧盟评估非转基因Cellulosimicrobiumfunkei菌株AE-AMT生产的α-淀粉酶的安全性

来源:好招商食品网 外讯导读   |  2024-04-25
   好招商食品网讯  2023年6月30日,欧盟食品安全局就一种α-淀粉酶(α-amylase)的安全性评价发布意见。
 
  据了解,这种食品酶是由非转基因Cellulosimicrobium funkei 菌株AE-AMT生产的,旨在用于烘焙过程、基于谷类的过程、用于生产乳制品类似物的植物加工、茶、草药和水果浸出物的加工、酿造过程和非葡萄酒醋的生产。
 
  经过评估,专家小组认为,这种食品酶在修订的预期使用条件下不会引起安全问题。部分原文报道如下:
 
  The food enzyme α-amylase (4-α-d-glucan glucanohydrolase; EC 3.2.1.1) is produced with the non-genetically modified Cellulosimicrobium funkei strain AE-AMT by Amano Enzyme Inc. In a previous opinion, a safety evaluation of this food enzyme was completed, in which EFSA concluded that this food enzyme did not give rise to safety concerns when used in starch processing for maltodextrin production. The applicant has now provided new data to extend the use of this food enzyme to six additional food manufacturing processes: baking processes, cereal-based processes, plant processing for the production of dairy analogues, processing of tea, herbal and fruit infusions, brewing processes and the production of non-wine vinegar. For its use in a total of seven food manufacturing processes, the dietary exposure to the food enzyme–total organic solids (TOS) was estimated to be up to 0.012 mg TOS/kg body weight (bw) per day in European populations. Using the toxicological data provided in the previous opinion, with a NOAEL of 230 mg TOS/kg bw per day (the highest dose tested), the Panel derived a margin of exposure of at least 19,167. based on the revised exposure calculation and the outcome of the previous evaluation, the Panel concluded that this food enzyme does not give rise to safety concerns under the revised intended conditions of use.
 

TAGS:淀粉酶 安全局 食品安全 欧盟 食品
免责声明:本站部分文章转载自网络,图文仅供行业学习交流使用,不做任何商业用途。文章仅代表原作者个人观点,其原创性及文章内容中图文的真实性、完整性等未经本站核实,仅供读者参考。
上一篇: 欧盟评估转基因棉花COT102用于食品和饲料中的安全性
下一篇: 欧盟评估苹果果实细胞培养生物质作为新型食品的安全性